tenk.fyi

Alpha Teknova, Inc.

TKNONasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$40.5M

7.4% YoY

Net Income

-$17.3M

35.5% YoY

EPS

$-0.32

43.9% YoY

Cash

$5.9M

59.4% YoY

FY 2025 · As of 2025-12-31